Caption Management, LLC Innoviva, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $257,013 - $338,175	-16,700 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$15.91 - $18.72 $1.59 Million - $1.87 Million	-100,000 Reduced 85.69%	16,700 $288,000
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $218,102 - $287,908	16,700 Added 16.7%	116,700 $1.95 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $1.15 Million - $1.4 Million	100,000 New	100,000 $1.34 Million
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $472,081 - $662,193	-45,700 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $597,480 - $793,520	-52,000 Reduced 53.22%	45,700 $639,000
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $18,653 - $35,029	-2,300 Reduced 2.3%	97,700 $1.15 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $1.01 Million - $1.46 Million	100,000 New	100,000 $1.05 Million

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.